OR WAIT null SECS
February 09, 2023
Biden outlined a host of priorities for improving health care and building the economy during State of the Union address.
February 08, 2023
Pharmapack Europe has announced the winners of the 2023 Pharmapack Awards spanning five categories across two dedicated awards.
Roche’s Phase III global program, centered around the biologic crovalimab as a treatment for paroxysmal nocturnal haemoglobinuria, showed the drug was non-inferior to current standards of care.
February 07, 2023
Clinicians, pediatric patients, regulators, and more are being considered to further strengthen focus on unmet medical needs.
The change would impact every package and hundreds of systems.
Thermo Fisher and Celltrio are introducing a new automation platform to address critical scale-up challenges in biotherapeutics.
Naoki Okamura, Astellas’ current chief strategy officer, will take over the role from Kenji Yasukawa.
CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.
iotaSciences isoPick is designed to expand handling solutions for cell biology and gene therapy applications.
February 06, 2023
The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing.